Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 11 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) (D02008) | 4件: Bosentan Bosentan,Macitentan, Sildenafil, Tadalafil | 5件: Bosentan
Bosentan
,Tadalafil (D02008), Bosentan , Sildenafil , Macitentan 💬 1. ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)
| 3件: EDNRA EDNRA,EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor inter ... | 1件: 86 86 💬1. ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan)
| ||||||||||||||||||
| 2 | FDC macitentan/tadalafil (D02008) | 2件: Macitentan Macitentan,Tadalafil | 2件: Tadalafil
Tadalafil
(D02008),Macitentan 💬 2. FDC macitentan/tadalafil
| 3件: EDNRA EDNRA,EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor inter ... | 1件: 86 86 💬2. FDC macitentan/tadalafil
| ||||||||||||||||||
| 3 | TADALAFIL (D02008) | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
(D02008) 💬3. TADALAFIL
| 1件: PDE5A PDE5A 💬3. TADALAFIL
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 💬
| ||||||||||||||||||
| 4 | Tadalafil 20 MG (D02008) | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
(D02008) 💬4. Tadalafil 20 MG
| 1件: PDE5A PDE5A 💬4. Tadalafil 20 MG
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬4. Tadalafil 20 MG
| ||||||||||||||||||
| 5 | Tadalafil 20 mg film-coated tablets (D02008) | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
(D02008) 💬5. Tadalafil 20 mg film-coated tablets
| 1件: PDE5A PDE5A 💬5. Tadalafil 20 mg film-coated tablets
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬5. Tadalafil 20 mg film-coated tablets
| ||||||||||||||||||
| 6 | Tadalafil 40 mg (D02008) | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
(D02008) 💬6. Tadalafil 40 mg
| 1件: PDE5A PDE5A 💬6. Tadalafil 40 mg
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬6. Tadalafil 40 mg
| ||||||||||||||||||
| 7 | Tadalafil and ambrisentan upfront combination therapy (D02008) | 2件: Ambrisentan Ambrisentan,Tadalafil | 2件: Tadalafil
Tadalafil
(D02008),Ambrisentan 💬 7. Tadalafil and ambrisentan upfront combination therapy
| 2件: EDNRA EDNRA,PDE5A 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways ... | 2件: 51 51, 86 💬
| ||||||||||||||||||
| 8 | Tadalafil and Sildenafil (D02008) | 2件: Sildenafil Sildenafil,Tadalafil | 2件: Tadalafil
Tadalafil
(D02008),Sildenafil 💬 8. Tadalafil and Sildenafil
| 1件: PDE5A PDE5A 💬8. Tadalafil and Sildenafil
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 113 113 💬8. Tadalafil and Sildenafil
| ||||||||||||||||||
| 9 | Tadalafil Citrate (D02008) | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
(D02008) 💬9. Tadalafil Citrate
| 1件: PDE5A PDE5A 💬9. Tadalafil Citrate
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 210 210 💬9. Tadalafil Citrate
| ||||||||||||||||||
| 10 | Tadalafil oral suspension (D02008) | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
(D02008) 💬10. Tadalafil oral suspension
| 1件: PDE5A PDE5A 💬10. Tadalafil oral suspension
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬10. Tadalafil oral suspension
|